The DEA approves synthetic marijuana as medicine while the real thing remains illegal

The DEA approves synthetic marijuana as medicine while the real thing remains illegal

Miroslav Tomoski | 25 November, 2017

In a historic case of hypocrisy, the DEA has proven that the scheduling of drugs under the Controlled Substances Act is totally arbitrary. It’s long been argued that the classification of substances as conducted by the DEA has been based on a minimal understanding of chemistry or proper facts. Now, the rescheduling of synthetic THC – the main psychoactive component in cannabis – while the plant remains illegal is the final nail in the coffin.

The announcement was made by the DEA the day before Thanksgiving, slipping past the radar of the regular news cycle. Dronabinol also was known as Syndros, a spray developed by pharmaceutical company Insys Therapeutics has been granted Schedule II classification, which recognizes its medicinal potential and allows for it to become a federally regulated prescription drug.

The DEA approves synthetic marijuana as medicine while the real thing remains illegal






Comments are Closed